(Q63591089)
Statements
A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (English)
0 references
June 2011
0 references
March 2012
0 references
49
0 references
18 year
0 references